Accuray (ARAY)
(Delayed Data from NSDQ)
$1.62 USD
-0.07 (-4.14%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.62 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth F Momentum F VGM
Brokerage Reports
Accuray Incorporated [ARAY]
Reports for Purchase
Showing records 161 - 180 ( 229 total )
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Q415 TOP LINE BEATS ESTIMATES BUT HIGHER EXPENSE OFFSET BETTER REVENUE
Provider: Obsidian Research Group
Analyst: WANN T
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Continued Progress on Turnaround. Key Points For Investors To Consider. Affirm Buy and $13 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Accuray Incorporated
Industry: Medical - Instruments
Solid Q4 Results and Continued Progress on Turnaround. Orders Encouraging. Expect Strong Revenue Growth And Margin Expansion Going Forward. Affirm Buy and $13 PT.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Company: Accuray Incorporated
Industry: Medical - Instruments
Building Traction With Strong Products And Improved Management. This Could Be The Inflection Point. Affirm Buy and Raise PT from $10 to $13.
Provider: COLLIERS SECURITIES
Analyst: O'NEIL B